Outcomes of patients admitted to the ICU for acute stroke: a retrospective cohort.


Journal

BMC anesthesiology
ISSN: 1471-2253
Titre abrégé: BMC Anesthesiol
Pays: England
ID NLM: 100968535

Informations de publication

Date de publication:
25 07 2022
Historique:
received: 04 04 2022
accepted: 15 07 2022
entrez: 25 7 2022
pubmed: 26 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

Although acute stroke is a leading cause of morbidity and mortality worldwide, data on outcomes of stroke patients requiring ICU admission are limited. We aimed to identify factors associated with a good neurological outcome (defined as a modified Rankin Scale score [mRS] of 0-2) 6 months after ICU admission. We retrospectively studied consecutive patients who were admitted to the ICU of a French university-affiliated hospital between January 2014 and December 2018 and whose ICD-10 code indicated acute stroke. Patients with isolated subarachnoid hemorrhage or posttraumatic stroke were excluded. The 323 identified patients had a median age of 67 [54.5-77] years; 173 (53.6%) were male. The main reasons for ICU admission were neurological failure (87%), hemodynamic instability (28.2%), acute respiratory failure (26%), and cardiac arrest (5.3%). At ICU admission, the Glasgow Coma Scale score was 6 [4-10] and the SAPSII was 54 [35-64]. The stroke was hemorrhagic in 248 (76.8%) patients and ischemic in 75 (23.2%). Mechanical ventilation was required in 257 patients (79.6%). Six months after ICU admission, 61 (19.5%) patients had a good neurological outcome (mRS, 0-2), 50 (16%) had significant disability (mRS, 3-5), and 202 (64.5%) had died; 10 were lost to follow-up. By multivariable analysis, factors independently associated with not having an mRS of 0-2 at 6 months were older age (odds ratio, 0.93/year; 95% confidence interval, 0.89-0.96; P < 0.01) and lower Glasgow Coma Scale score at ICU admission (odds ratio, 1.23/point; 95% confidence interval, 1.07-1.40; P < 0.01). Acute stroke requiring ICU admission carried a poor prognosis, with less than a fifth of patients having a good neurological outcome at 6 months. Age and depth of coma independently predicted the outcome.

Sections du résumé

BACKGROUND
Although acute stroke is a leading cause of morbidity and mortality worldwide, data on outcomes of stroke patients requiring ICU admission are limited. We aimed to identify factors associated with a good neurological outcome (defined as a modified Rankin Scale score [mRS] of 0-2) 6 months after ICU admission.
METHODS
We retrospectively studied consecutive patients who were admitted to the ICU of a French university-affiliated hospital between January 2014 and December 2018 and whose ICD-10 code indicated acute stroke. Patients with isolated subarachnoid hemorrhage or posttraumatic stroke were excluded.
RESULTS
The 323 identified patients had a median age of 67 [54.5-77] years; 173 (53.6%) were male. The main reasons for ICU admission were neurological failure (87%), hemodynamic instability (28.2%), acute respiratory failure (26%), and cardiac arrest (5.3%). At ICU admission, the Glasgow Coma Scale score was 6 [4-10] and the SAPSII was 54 [35-64]. The stroke was hemorrhagic in 248 (76.8%) patients and ischemic in 75 (23.2%). Mechanical ventilation was required in 257 patients (79.6%). Six months after ICU admission, 61 (19.5%) patients had a good neurological outcome (mRS, 0-2), 50 (16%) had significant disability (mRS, 3-5), and 202 (64.5%) had died; 10 were lost to follow-up. By multivariable analysis, factors independently associated with not having an mRS of 0-2 at 6 months were older age (odds ratio, 0.93/year; 95% confidence interval, 0.89-0.96; P < 0.01) and lower Glasgow Coma Scale score at ICU admission (odds ratio, 1.23/point; 95% confidence interval, 1.07-1.40; P < 0.01).
CONCLUSIONS
Acute stroke requiring ICU admission carried a poor prognosis, with less than a fifth of patients having a good neurological outcome at 6 months. Age and depth of coma independently predicted the outcome.

Identifiants

pubmed: 35879652
doi: 10.1186/s12871-022-01777-4
pii: 10.1186/s12871-022-01777-4
pmc: PMC9310455
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

235

Informations de copyright

© 2022. The Author(s).

Références

Intensive Care Med. 2003 Aug;29(8):1237-44
pubmed: 12756437
Crit Care Med. 2001 Sep;29(9):1792-7
pubmed: 11546988
JAMA. 2019 Oct 8;322(14):1392-1403
pubmed: 31593272
Neurology. 2007 May 15;68(20):1651-7
pubmed: 17502545
J Neurol Sci. 2008 Jul 15;270(1-2):60-6
pubmed: 18299138
J Neurosurg. 1968 Jan;28(1):14-20
pubmed: 5635959
Stroke. 1994 Nov;25(11):2220-6
pubmed: 7974549
Intensive Care Med. 2017 Feb;43(2):271-272
pubmed: 27695893
Crit Care Med. 2018 Jul;46(7):1085-1092
pubmed: 29608513
BMC Neurol. 2008 Jun 26;8:24
pubmed: 18582387
J Formos Med Assoc. 2006 Aug;105(8):653-8
pubmed: 16935766
Crit Care Med. 2017 Feb;45(2):e138-e145
pubmed: 27749342
Ann Intensive Care. 2020 May 7;10(1):53
pubmed: 32383104
Stroke. 2007 Mar;38(3):1091-6
pubmed: 17272767
Crit Care Explor. 2021 Feb 22;3(2):e0341
pubmed: 33634264
Cerebrovasc Dis. 2015;40(1-2):10-7
pubmed: 26022716
Intensive Care Med. 2014 May;40(5):640-53
pubmed: 24658914
Crit Care Med. 2011 Jan;39(1):158-62
pubmed: 21037471
Neurocrit Care. 2015 Aug;23(1):28-32
pubmed: 25487123
J Neurol. 2005 Oct;252(10):1249-54
pubmed: 15917980
Anaesth Intensive Care. 2002 Oct;30(5):628-32
pubmed: 12413265
J Stroke Cerebrovasc Dis. 2004 Jul-Aug;13(4):183-8
pubmed: 17903973
Scott Med J. 1957 May;2(5):200-15
pubmed: 13432835
J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104361
pubmed: 31515185
Stroke. 2013 Oct;44(10):2854-61
pubmed: 23920019
Lancet Neurol. 2007 Mar;6(3):215-22
pubmed: 17303527
Cochrane Database Syst Rev. 2013 Sep 11;(9):CD000197
pubmed: 24026639
J Neurol Neurosurg Psychiatry. 1988 Nov;51(11):1457
pubmed: 3236024
Lancet. 2007 Jan 27;369(9558):299-305
pubmed: 17258670
Intensive Care Med. 2015 Feb;41(2):318-21
pubmed: 25398306
Intensive Care Med. 2014 May;40(5):749-51
pubmed: 24711090
Crit Care Med. 2009 Dec;37(12):3107-13
pubmed: 19661805
Stroke. 2000 Oct;31(10):2346-53
pubmed: 11022062
Lancet Neurol. 2019 May;18(5):439-458
pubmed: 30871944
JAMA. 2005 Aug 10;294(6):725-33
pubmed: 16091575
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
Stroke. 2001 Apr;32(4):891-7
pubmed: 11283388
J Neurol Neurosurg Psychiatry. 1991 Dec;54(12):1044-54
pubmed: 1783914
J Clin Neurosci. 2015 Jan;22(1):111-5
pubmed: 25172016
N Engl J Med. 2008 Sep 25;359(13):1317-29
pubmed: 18815396

Auteurs

Thibaut Carval (T)

Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nantes, Centre Hospitalier Universitaire Hôtel-Dieu, 30 Bd. Jean Monnet, 44093 Nantes Cedex 1, Nantes, France.

Charlotte Garret (C)

Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nantes, Centre Hospitalier Universitaire Hôtel-Dieu, 30 Bd. Jean Monnet, 44093 Nantes Cedex 1, Nantes, France.

Benoît Guillon (B)

Service de Neurologie, Centre Hospitalier Universitaire de Nantes, Université de Nantes, Nantes, France.

Jean-Baptiste Lascarrou (JB)

Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nantes, Centre Hospitalier Universitaire Hôtel-Dieu, 30 Bd. Jean Monnet, 44093 Nantes Cedex 1, Nantes, France.

Maëlle Martin (M)

Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nantes, Centre Hospitalier Universitaire Hôtel-Dieu, 30 Bd. Jean Monnet, 44093 Nantes Cedex 1, Nantes, France.

Jérémie Lemarié (J)

Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nantes, Centre Hospitalier Universitaire Hôtel-Dieu, 30 Bd. Jean Monnet, 44093 Nantes Cedex 1, Nantes, France.

Julien Dupeyrat (J)

Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nantes, Centre Hospitalier Universitaire Hôtel-Dieu, 30 Bd. Jean Monnet, 44093 Nantes Cedex 1, Nantes, France.

Amélie Seguin (A)

Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nantes, Centre Hospitalier Universitaire Hôtel-Dieu, 30 Bd. Jean Monnet, 44093 Nantes Cedex 1, Nantes, France.

Olivier Zambon (O)

Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nantes, Centre Hospitalier Universitaire Hôtel-Dieu, 30 Bd. Jean Monnet, 44093 Nantes Cedex 1, Nantes, France.

Jean Reignier (J)

Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nantes, Centre Hospitalier Universitaire Hôtel-Dieu, 30 Bd. Jean Monnet, 44093 Nantes Cedex 1, Nantes, France.

Emmanuel Canet (E)

Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nantes, Centre Hospitalier Universitaire Hôtel-Dieu, 30 Bd. Jean Monnet, 44093 Nantes Cedex 1, Nantes, France. emmanuel.canet@chu-nantes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH